Evidence map›Paper›PMID 19194496›Full record

ArticlePloS one2009

Transposition-based method for the rapid generation of gene-targeting vectors to produce Cre/Flp-modifiable conditional knock-out mice.

Hilkka Turakainen, Jonna Saarimäki-Vire, Natalia Sinjushina, Juha Partanen, Harri Savilahti

Abstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The autism diagnosis in translation: shared affect in children and mouse models of ASD.Autism research : official journal of the International Society for Autism Research · 2011
    Review
  10. Review
  11. FLPe functions in zebrafish embryos.Transgenic research · 2011
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hilkka TurakainenProgram in Cellular Biotechnology, Institute of Biotechnology, Viikki Biocenter, University of Helsinki, Helsinki, Finland.
Jonna Saarimäki-Vire
Natalia Sinjushina
Juha Partanen
Harri Savilahti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conditional gene targeting strategies are progressively used to study gene function tissue-specifically and/or at a defined time period. Instrumental to all of these strategies is the generation of targeting vectors, and any methodology that would streamline the procedure would be highly beneficial. We describe a comprehensive transposition-based strategy to produce gene-targeting vectors for the generation of mouse conditional alleles. The system employs a universal cloning vector and two custom-designed mini-Mu transposons. It produces targeting constructions directly from BAC clones, and the alleles generated are modifiable by Cre and Flp recombinases. We demonstrate the applicability of the methodology by modifying two mouse genes, Chd22 and Drapc1. This straightforward strategy should be readily suitable for high-throughput targeting vector production.

Indexed as

AllelesAnimalsAttachment Sites, MicrobiologicalCadherinsDNA NucleotidyltransferasesDNA Transposable ElementsEmbryonic Stem CellsGene TargetingGenetic VectorsIntegrasesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceMice, KnockoutPolymerase Chain ReactionReproducibility of ResultsApcdd1 protein, mouseCadherinsCdh22 protein, mouseCre recombinaseDNA NucleotidyltransferasesDNA Transposable ElementsFLP recombinaseIntegrasesIntracellular Signaling Peptides and ProteinsMembrane Proteins

Identifiers

PMID19194496
PMCPMC2632748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.